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Increased maternal TSH and decreased
maternal FT4 are associated with a higher
operative delivery rate in low-risk
pregnancies: A prospective cohort study
L. Monen1,2,3*, VJ Pop1, TH Hasaart2, H. Wijnen4, SG Oei5 and SM Kuppens2
Abstract
Background: The increasing number of operative deliveries is a topic of major concern in modern obstetrics.
Maternal thyroid function is of known influence on many obstetric parameters. Our objective was to investigate
a possible relation between maternal thyroid function, and operative deliveries. Secondary aim was to explore
whether thyroid function was related to specific reasons for operative deliveries.
Methods: In this prospective cohort study, low-risk Caucasian women, pregnant of a single cephalic fetus were
included. Women with known auto-immune disease, a pre-labour Caesarean section, induction of labour, breech
presentation or preterm delivery were excluded. In all trimesters of pregnancy the thyroid function was assessed.
Differences in mean TSH and FT4 were assessed using t-test. Mean TSH and FT4 levels for operative deliveries
were determined by one way ANOVA. Repeated measurement analyses were performed (ANOVA), adjusting for
BMI, partiy, maternal age and gestational age at delivery.
Results: In total 872 women were included, of which 699 (80.2 %) had a spontaneous delivery. At 36 weeks
gestation women who had an operative delivery had a significantly higher mean TSH (1.63mIU/L versus 1.46mIU/
L, p = 0.025) and lower mean FT4 (12.9pmol/L versus 13.3pmol/L, p = 0.007)) compared to women who had a
spontaneous delivery. Mean TSH was significantly higher (p = 0.026) and mean FT4 significantly lower (p = 0.030)
throughout pregnancy for women with an operative delivery due to failure to progress in second stage of labour,
compared to women with a spontaneous delivery or operative delivery for other reasons.
Conclusions: Increased TSH and decreased FT4 seem to be associated with more operative vaginal deliveries and
Caesarean sections. After adjusting for several confounders the association remained for operative deliveries due
to failure to progress in second stage of labour, possibly to be explained by less efficient uterine action.
Keywords: Maternal thyroid function, Failure to progress, Dystocia, Caesarean section, Operative delivery
Background
Increasing rates of Caesarean Sections (CS) is a topic of
major concern in obstetrics. Both the incidences of
planned and emergency CS are rising, without necessar-
ily better neonatal outcomes [1, 2]. Operative vaginal de-
liveries (OVD) have a slowly decreasing trend, but OVD
are still common, especially in nulliparous women [1].
Maternal morbidity and mortality rates are higher for
women with a CS or OVD [2, 3]. Many studies have
been performed to determine risk factors associated
with operative deliveries. The main risk factors for CS
and OVD are nulliparity, induction of labour, increasing
maternal age, abnormal position of the fetus, high ma-
ternal body mass index (BMI) and previous CS [4–6].
Most CS and OVD are performed due to failure to pro-
gress, especially in nulliparous women [6]. The main
reason is inefficient uterine action and to a lesser extent
* Correspondence: loes_monen@hotmail.com
1Department of Medical Health Psychology, Tilburg University Warandelaan,
2, 5037 AB, Tilburg, The Netherlands
2Department of Obstetrics and Gynaecology, Catharina Hospital,
Michelangelolaan 2, 5613 EJ Eindhoven, The Netherlands
Full list of author information is available at the end of the article
© 2015 Monen et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Monen et al. BMC Pregnancy and Childbirth  (2015) 15:267 
DOI 10.1186/s12884-015-0702-1
cephalopelvic disproportion. In fact, efficient uterine
action is more and more considered as the key to nor-
mal delivery [7, 8].
In previous studies it has been demonstrated that
suboptimal maternal thyroid function (high maternal
thyrotrophine stimulating hormone (TSH) and low free
thyroxine (FT4)) is associated with adverse pregnancy
outcomes [9–12]. Women with suboptimal thyroid
function, mainly those with TPO-antibodies (thyroid-
peroxidase-antibody), are at risk for miscarriage and
preterm birth [9, 10]. Furthermore, there is evidence
that high maternal TSH might interfere with normal
obstetric outcome at term, with higher incidences of
small for gestational age neonates [11], gestational dia-
betes [10] and meconium stained amniotic fluid [12].
Low FT4 has been associated with poor fetal neurode-
velopment and psychomotor development in early
childhood [13].
Little research is done into the relation between ma-
ternal thyroid function and uterine contractions. How-
ever, there is some evidence that suboptimal maternal
thyroid function might be associated with more breech
presentations, possibly due to increased stiffness of the
myometrium [14]. This increased stiffness in patients
with suboptimal thyroid function has been demon-
strated in previous research in vascular smooth muscle
cells as well [15, 16].
In the current study we evaluated a possible relation-
ship between suboptimal maternal thyroid function
and inefficient uterine action at term. Primary objective
was to investigate a possible relation between maternal
thyroid function and incidence of CS and OVD. Sec-
ondary objective was to explore whether thyroid func-
tion was related to specific reasons for operative
deliveries: due to fetal distress or failure to progress. In
order to create a representative low-risk group we ex-
cluded the women at high risk for operative deliveries




Between January 1997 and April 1998, 1702 women
who booked for antenatal visits at 12 weeks gestation
were followed in five community midwife practices in
the vicinity of Eindhoven (the Netherlands). Only
Dutch Caucasian women were eligible to avoid lan-
guage problems and confounding factors of ethnicity.
General patient characteristics including BMI, educa-
tion level, smoking status, maternal age and parity were
collected. Information of possible previous pregnancies
was collected. A cohort of women at low-risk for
obstetric complications was defined, with the exclusion
of preterm deliveries, breech presentations, multiple
pregnancies and induction of labour. Women on thy-
roid medication, with type I diabetes and with a new
diagnosis of overt hyper- or hypothyroidism at first
screening were excluded. Delivery was considered an
OVD when there was a ventouse or forceps delivery. In
cases without CS or OVD, delivery was defined as
spontaneous. The reasons for OVD and CS were classi-
fied as fetal distress, failure to progress in first stage of
labour (prolonged dilatation) or failure to progress in
second stage of labour (prolonged expulsion). Fetal dis-
tress was defined as a non-reassuring fetal heart rate
with cardiotocography, as assessed by the responsible
obstetrician using the FIGO classification.
The selection process is shown in Fig. 1 and the char-
acteristics are shown in Table 1. This study was ap-
proved by the Medical Ethical Committee of Máxima
Medical Centre in Eindhoven/Veldhoven. (METC pro-
ject number: 0116) and written informed consent was
obtained from all participants.
Analysis
TSH was measured in serum at 12, 24 and 36 weeks
using a solid-phase, two site chemiluminescent enzyme
immunometric assay (IMMULITE Third generation
Exclusion
Pre-term delivery N=60 (1051)
Primary CS N=50 (1001)
Breech presentation N=5 (996)
Induction of labour N=124 (872)
Missing data N=37 (1111)
Exclusion
Women on thyroid medication N=21 (1176)
Hypothyroid N=1 (1175)
Hyperthyroid N=6 (1169)
Pregnant after hormonal stimulation N=8 (1161)
Multiple pregnancy N=8 (1153)
Type I diabetes N=5 (1148)
Egligible. N=1197




Not Ducth Caucasian (N=179)
Fig. 1 Selection process
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TSH, Diagnostic Products Corporation, Los Angeles
USA). The inter-assay coefficients of variation were
5.0 % and 4.4 % at concentrations 0.22 mIU/L and
2.9mIU/L, respectively. The non-pregnant reference
range of TSH is 0.45 - 4.5 mIU/L. FT4 concentration
was measured in serum at 12, 24 and 36 weeks with a
solid-phase immunometric assay (IMMULITE Free
T4). The inter-assay coefficients of variation for this
technique were 6.7 % and 4.4 % at concentrations of
11.6 pmol/L and 31.5 pmol/L, respectively. TPO-
Antibodies were determined in serum at 12, 24 and
36 weeks by means of the IMMULITE Anti-TPO-Ab
kit. The inter-assay coefficients of variation for this
analysis were 9 % and 9.5 % for concentrations of 40
kU/ml and 526 kU/ml, respectively. The anti-TPO
assay is standardized in terms of the International Ref-
erence Preparation for anti-TPO MRC 66/387. Women
were defined as TPO-Ab-negative when the titer was
below 35 kU/ml at 12 weeks gestation. The highest
TSH level found in our sample was 6.1 mIU/L. All
measurements were performed in one laboratory.
Statistical analysis
Statistical analysis was performed using the Statistical
Package of Social Science (SPSS, 19.0). There were
missing data in 37 cases, which were excluded from
further analysis. The data from women who gave in-
formed consent did not differ from the non-responders
regarding maternal age, educational level and parity.
TSH and FT4 concentrations were not normally dis-
tributed. However, because the cohort size of all sub-
groups was substantial (n > 30) we were able to calculate
differences in means (SD) of thyroid hormones concentra-
tion levels using Welch T-test (two-tailed). Differences in
prevalence were calculated by chi-square. Subsequently,
repeated measures ANOVA was performed to deter-
mine whether the changes of TSH and FT4 during
pregnancy were associated with the mode of delivery
and the different reasons for OVD or CS. We compared
the changes of mean FT4 and TSH throughout preg-
nancy in women with and without a spontaneous deliv-
ery using repeated measurement analyses, adjusting for
various selected confounders such as parity, gestational
Table 1 Characteristics of a group of 872 women who delivered at term (≥37 weeks of gestation), comparing spontaneous
deliveries and operative vaginal deliveries or secondary CS. Primary CS’s were excluded
All deliveries (872) Spontaneous deliveries (747) Operative deliveries (125) p-value
Mean (SD) N(%) Mean (SD) N(%) Mean (SD) N(%) t-test X2
Age ≥35 yrs 30.5(3.6) 30.6 (3.7) 30.0 (3.4) 0.08
Low education 69 (8) 62 (8) 7 (6) 0.47
BMI before pregnancy(kg/m2) 25.2(4.3) 25.0 (4.2) 26.3(4.7) 0.002
Primiparity 366(42) 268(36) 98 (78) <0.001
Miscarriage in obstetric history 164(19) 148(20) 16 (13) 0.06
Smoking 108(12) 89 (12) 19 (15) 0.30
Thyroid function
12 weeks gestation
TSH (mIU/L) 1.30 (2.97) 1.21(0.80) 1.88 (0.76) 0.33
FT4 (pmol/L) 16.2 (2.5) 16.2 (2.5) 16.2 (2.5) 0.98
24 weeks gestation
TSH (mIU/L) 1.33 (0.69) 1.32(0.65) 1.45(0.89) 0.11
FT4 (pmol/L) 13.9 (2.0) 13.9 (2.0) 13.7 (1.8) 0.20
36 weeks gestation
TSH (mIU/L) 1.49 (0.75) 1.46(0.73) 1.63(0.86) 0.025
FT4 (pmol/L) 13.3 (2.2) 13.4 (2.2) 12.9 (2.1) 0.007
TPO-Ab >35 IU/mL 75 (8.6) 60 (8.0) 15(12.0) 0.14
Family history thyroid dysfunction 158(18) 137(18) 21 (17) 0.80
Neonatal outcome:
Term at delivery (wks) 39.9(1.1) 39.8 (1.1) 40.3 (1.0) <0.001
Birth weight (gr) 3545(457) 3539(457) 3582(454) 0.33
Male offspring 451(52) 380(51) 71(57) 0.20
*Variables in bold are statistically significant (P < 0.05)
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age, BMI and maternal age, as these are all of known
influence on the risk of an operative delivery.
Results
Table 1 shows that women who undergo an operative
delivery have a higher pre-pregnancy BMI (26.3 kg/m2
versus 25.0 kg/m2) (p = 0.002) and have a longer gesta-
tional age (40.3 versus 39.8 weeks gestation) (p < 0.001).
There were no statistically significant differences be-
tween a history of thyroid dysfunction in the family or
the prevalence of positive TPO-antibodies. However, at
36 weeks gestation (third trimester) women who had
an OVD or CS had a significantly higher mean TSH
and lower mean FT4 compared to women who had a
spontaneous delivery (TSH 1.63 mIU/L versus 1.46
mIU/L (p = 0.025) and FT4 12.9 pmol/L versus 13.4
pmol/L (p = 0.007) respectively). The 75 women with
elevated TPO-Ab titres had significantly (T-test, two
tailed, P < 0.001) higher mean TSH at 12, 24 and
36 weeks gestation compared to the remaining TPO-
Ab negative women: 1.80 (SD: 1.21) versus 1.14 (0.68),
1.69 (SD0.98) versus 1.29 (0.60), 1.73 (SD:1.01) versus
1.46 (SD: 0.70), respectively. In the 797 TPO-Ab nega-
tive women at 12 weeks, we calculated the 2.5 and 97.5
percentile of TSH to define the normal reference range of
TSH, this was 0.13 2.8 mIU/l. Subsequently we were able
to assess the number of women with hypothyroxinemia at
12 weeks gestation: FT4 < 10th percentile (< 13.4 pmol/l)
with normal TSH values: 79 (9.1 %).
The different modes of delivery and the reasons for
OVD and CS are shown in Table 2. 80.2 % of the women
had a spontaneous delivery and in 19.8 % of the women
an OVD or CS was performed. In 5.8 % of the deliveries
there was an OVD or CS due to failure to progress in
first stage of labour, in 7.9 % of the deliveries there was
failure to progress in second stage of labour and 6.1 % of
all deliveries were terminated due to fetal distress. Mean
FT4 and mean TSH were compared between these sub-
groups using one way ANOVA. As shown in Table 2,
mean TSH was significantly higher at 12 weeks of gesta-
tion (p = 0.010) and at showed a trend at 24 (p = 0.093)
and 36 weeks gestation (p = 0.066) for women with an
operative delivery due to failure to progress in second
stage of labour. Mean FT4 was lower at a 90 % signifi-
cance level at the first and third trimester of pregnancy
for women with failure to progress in second stage of
labour (p = 0.07, p = 0.16, p = 0.08 respectively).
As shown in Fig. 2, women who had an OVD or CS
for failure to progress in the second stage of labour (de-
layed expulsion) had higher mean TSH levels (p = 0.026)
at all trimester adjusted for age, parity, BMI and gesta-
tional age, compared to women who had a spontaneous
delivery or an OVD or CS for other reasons. TSH was
also significantly associated with parity. In Fig. 3 it is
shown that women with an OVD or CS for failure to
progress in second stage of labour, had a significant
lower mean FT4 in all trimesters (p = .0.030), adjusted
for age (p < 0.001), parity (p = 0.26), BMI (p < 0.001) and
gestational age (0.44), compared to women with a
spontaneous delivery or OVD or CS for other reasons
(see Table 3). There were no differences in maternal thy-
roid function between women who had a spontaneous
delivery compared to women who underwent an OVD
or CS for fetal distress or failure to progress in the first
Table 2 Mode of delivery in 872 women at term in whom labour started spontaneouslyANOVA analyses for influence of maternal
thyroid function at every trimester on mode of delivery (df = 3)
Spontaneous
delivery
Failure to progress in 1st stage of labour
(prolonged dilatation)





































13.4 (1.9) 13.4 (2.2) 12.7 (1.9) 13.3 (2.1) 0.080
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stage of labour (delayed dilatation). When we repeated
the analyses excluding women with hypothyroxinemia,
similar results were found (data not shown).
Discussion
In this study we found a significant association between
high normal maternal TSH and low normal FT4 and the
risk of operative delivery for women in spontaneous
labour at term, not accounted for confounders. Our co-
hort consisted of 872 Caucasian women with a low-risk
pregnancy. Planned Caesarean sections, inductions of
labour, preterm deliveries and breech presentations were
excluded. Our cohort was representative in terms of
thyroid function and obstetric outcome. We did find a
higher incidence of TPO-Ab in our study (8.6 %) com-
pared to another large cohort study in the Netherlands
(5.6 %) [17], but this can be explained by 40 % black
women in their population, in whom TPO-Ab are less
frequently found [18], while our sample included only
white Caucasian women. Mean TSH and FT4 levels of
the current study are comparable to their sample. Ob-
stetric outcome was proportionate to a large cohort
study carried out in the Netherlands to analyse trends in
obstetric interventions[1]. They found a CS rate of 7.5 %
for nulliparous women in spontaneous labour and an






















Fig. 2 The relation between mean TSH at all trimesters and the mode of delivery in 872 term women in whom labour started spontaneously:
women who had an operative vaginal delivery or Caesarean section because of prolonged expulsion had significantly higher mean TSH



















Fig. 3 The relation between mean FT4 at three trimesters and the mode of delivery in 872 term women in whom labour started spontaneously:
women who had an operative vaginal delivery or Caesarean section because of prolonged expulsion had significantly lower mean FT4 throughout
gestation (repeated measures ANOVA, F = 3.0, p = 0.030), adjusted for age, parity, gestational age and BMI
Monen et al. BMC Pregnancy and Childbirth  (2015) 15:267 Page 5 of 8
an increase in CS rates over the years [1]. Our total op-
erative delivery rate was 20 %, for OVD and CS
combined.
The current study showed that women who undergo a
CS or OVD had a higher pre-pregnancy BMI and deliv-
ered at a later gestational age. This finding is consistent
with previous reports [8, 19–21]. We also found that
women with an operative delivery for failure to progress
in second stage of labour had higher mean TSH levels
and lower mean FT4 levels throughout pregnancy, com-
pared to women who delivered spontaneously or had an
operative delivery for another reason. This finding was
adjusted for maternal age, pre-pregnancy BMI, parity
and gestational age at time of delivery.
Strength and limitations
One of the main strengths of this study is the fact that
maternal thyroid function was assessed prospectively
throughout pregnancy at fixed time-intervals. Repeated
measurement analysis was performed to assess changes
in thyroid function within and between subjects. Fur-
thermore, we corrected for important confounders, in-
cluding BMI, which is one of the known risk factors for
operative deliveries [8, 19, 20]. We have not used cut off
values for suboptimal maternal thyroid function. We be-
lieve that this is a major strength of this study, as there
is considerable discussion about the proper cut off
values and the definition of, for example, subclinical
hypothyroidism in pregnancy [22, 23].
A limitation of the study is the fact that this was an
observational study and therefore no conclusions on
causality of the associations can be drawn. Furthermore,
no strict definitions of fetal distress were used. Diagnosis
of fetal distress was made on the basis of a non-
reassuring fetal heart pattern. As only healthy Dutch
Caucasian women were analysed in this study, extrapola-
tion of the results to women with other ethnicities or to
high risk pregnant women with for example hyperten-
sion or diabetes must be taken with caution. Further-
more, we did not consider iodine status in our cohort.
However, it is known that in this region iodine intake is
generally sufficient [24].
Interpretation
Higher TSH and lower FT4 in this euthyroid sample
were associated with higher operative delivery rates.
However, TSH and FT4 were still in the normal ranges
for all groups. In a large retrospective cohort study from
Männistö et al. increased odds for CS (both prelabour
and during labour) were found in women with primary
hypothyroidism [25]. From that study however, it was
not clear for what reasons the CS were performed.
The main difference in the current study, according to
maternal TSH and FT4, is found in OVD and CS due to
failure to progress in second stage of labour. It is known
that the most important factor in the expulsion of the
fetus is the thickness of the myometrium and thus the
strength of the contractions, despite the pushing efforts
of the mother [26]. It has not been well established
whether the spontaneous contractions are stronger dur-
ing the second stage of labour than during the first stage
of labour, but it is known that during Valsalva the power
of the contractions is significantly higher in the second
stage of labour [27]. With Valsalva it is not only smooth
muscle cell contractions, but contractions of the skel-
eton muscles of the abdominal wall as well, that deter-
mine the expulsive power. It is well known that thyroid
hormones are of influence on the contractile phenotype
of skeletal muscles [28]. The most effective uterine ac-
tion is needed in the second stage of labour and factors
that are of influence on the strength of the contractions
will therefore become most apparent during this stage.
Calcium influx is necessary for excitation of the
smooth muscle cells and therefore for the myometrial
contractility required during labour. Parija et al. have
demonstrated that hypothyroidism reduces calcium
channel function in uterine tissue of the pregnant rat
[29]. A study from Corriveau et al. has found that the
amplitude and time course of contractions is enhanced
in patients treated with thyroid hormone compared to
controls [30]. This suggests that thyroid function is of
direct influence on myometrial contractility. Besides the
absolute strength of the contractions, it has also been
found in vascular research that hypothyroidism leads to
impaired smooth muscle cell relaxation, leading to in-
creased artertial stiffness [15, 16]. Moreover, women
with failed external cephalic version had higher TSH
values, probably because of impaired uterine relaxation
which is essential for the breech baby to turn [31]. The
Table 3 The relation between mean TSH and mean FT4
throughout gestation in term women in spontaneous labour,
corrected for multiple counfounders
F p-value
Mean TSH
Reason for operative delivery 3.107 0.026
Parity 5.005 0.026
Gestational age 0.037 0.85
Body Mass Index 0.007 0.93
Maternal age 0.716 0.40
Mean FT4
Reason for operative delivery 3.006 0.030
Parity 1.276 0.26
Gestational age 0.605 0.44
Body Mass Index 16.469 <0.001
Maternal age 18.798 <0.001
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combination of the strength of the contractions and the
impaired relaxation of the myometrium might lead to
less efficient uterine action in women with suboptimal
thyroid function in this study. Future research should
confirm this finding in a larger population and deter-
mine whether treatment of suboptimal maternal thyroid
function leads to less failure to progress. In our cohort
the mean TSH and FT4 were all in the normal reference
ranges for the pregnant population.
Conclusions
Increased TSH and decreased FT4 seem to be associated
with more operative vaginal deliveries and Caesarean
sections. After adjusting for several confounders the as-
sociation remained for operative deliveries due to failure
to progress in second stage of labour, possibly to be ex-
plained by less efficient uterine action. The conclusions
of this study are very relevant, as the increasing inci-
dence of CS is one of the major concerns in modern ob-
stetrics. Future research should confirm our findings
and focus on determining the direct effect of maternal
thyroid hormones on uterine contractions in vivo.
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